Cargando…
A rolling phenotype in Crohn's disease
BACKGROUND AND AIM: The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn’s disease complications, the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383106/ https://www.ncbi.nlm.nih.gov/pubmed/28384331 http://dx.doi.org/10.1371/journal.pone.0174954 |
_version_ | 1782520221892870144 |
---|---|
author | Irwin, James Ferguson, Emma Simms, Lisa A. Hanigan, Katherine Carbonnel, Franck Radford-Smith, Graham |
author_facet | Irwin, James Ferguson, Emma Simms, Lisa A. Hanigan, Katherine Carbonnel, Franck Radford-Smith, Graham |
author_sort | Irwin, James |
collection | PubMed |
description | BACKGROUND AND AIM: The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn’s disease complications, the rolling phenotype. As is commonly observed in clinical practice, this definition allows progression to a more severe phenotype (stricturing, penetrating) but also, regression to a less severe behaviour (inflammatory, or remission) over time. METHODS: All patients diagnosed with Crohn's Disease between 01/01/1994 and 01/03/2008, managed at a single centre and observed for a minimum of 5 years, had development and resolution of all complications recorded. A rolling phenotype was defined at each time point based on all observed complications in the three years prior to the time point. Phenotype was defined as B1, B2, B3, or B23 (penetrating and stenotic). The progression over time of the rolling phenotype was compared to that of the cumulative Montreal phenotype. RESULTS: 305 patients were observed a median of 10.0 (Intraquartile range 7.3–13.7) years. Longitudinal progression of rolling phenotype demonstrated a consistent proportion of patients with B1 (70%), B2 (20%), B3 (5%) and B23 (5%) phenotypes. These proportions were observed regardless of initial phenotype. In contrast, the cumulative Montreal phenotype progressed towards a more severe phenotype with time (B1 (39%), B2 (26%), B3(35%) at 10 years). CONCLUSION: A rolling phenotype provides an alternative view of the longitudinal burden of intra-abdominal complications in Crohn's disease. From this viewpoint, 70% of patients have durable freedom from complication over time (>3 years). |
format | Online Article Text |
id | pubmed-5383106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53831062017-05-03 A rolling phenotype in Crohn's disease Irwin, James Ferguson, Emma Simms, Lisa A. Hanigan, Katherine Carbonnel, Franck Radford-Smith, Graham PLoS One Research Article BACKGROUND AND AIM: The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn’s disease complications, the rolling phenotype. As is commonly observed in clinical practice, this definition allows progression to a more severe phenotype (stricturing, penetrating) but also, regression to a less severe behaviour (inflammatory, or remission) over time. METHODS: All patients diagnosed with Crohn's Disease between 01/01/1994 and 01/03/2008, managed at a single centre and observed for a minimum of 5 years, had development and resolution of all complications recorded. A rolling phenotype was defined at each time point based on all observed complications in the three years prior to the time point. Phenotype was defined as B1, B2, B3, or B23 (penetrating and stenotic). The progression over time of the rolling phenotype was compared to that of the cumulative Montreal phenotype. RESULTS: 305 patients were observed a median of 10.0 (Intraquartile range 7.3–13.7) years. Longitudinal progression of rolling phenotype demonstrated a consistent proportion of patients with B1 (70%), B2 (20%), B3 (5%) and B23 (5%) phenotypes. These proportions were observed regardless of initial phenotype. In contrast, the cumulative Montreal phenotype progressed towards a more severe phenotype with time (B1 (39%), B2 (26%), B3(35%) at 10 years). CONCLUSION: A rolling phenotype provides an alternative view of the longitudinal burden of intra-abdominal complications in Crohn's disease. From this viewpoint, 70% of patients have durable freedom from complication over time (>3 years). Public Library of Science 2017-04-06 /pmc/articles/PMC5383106/ /pubmed/28384331 http://dx.doi.org/10.1371/journal.pone.0174954 Text en © 2017 Irwin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Irwin, James Ferguson, Emma Simms, Lisa A. Hanigan, Katherine Carbonnel, Franck Radford-Smith, Graham A rolling phenotype in Crohn's disease |
title | A rolling phenotype in Crohn's disease |
title_full | A rolling phenotype in Crohn's disease |
title_fullStr | A rolling phenotype in Crohn's disease |
title_full_unstemmed | A rolling phenotype in Crohn's disease |
title_short | A rolling phenotype in Crohn's disease |
title_sort | rolling phenotype in crohn's disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383106/ https://www.ncbi.nlm.nih.gov/pubmed/28384331 http://dx.doi.org/10.1371/journal.pone.0174954 |
work_keys_str_mv | AT irwinjames arollingphenotypeincrohnsdisease AT fergusonemma arollingphenotypeincrohnsdisease AT simmslisaa arollingphenotypeincrohnsdisease AT hanigankatherine arollingphenotypeincrohnsdisease AT carbonnelfranck arollingphenotypeincrohnsdisease AT radfordsmithgraham arollingphenotypeincrohnsdisease AT irwinjames rollingphenotypeincrohnsdisease AT fergusonemma rollingphenotypeincrohnsdisease AT simmslisaa rollingphenotypeincrohnsdisease AT hanigankatherine rollingphenotypeincrohnsdisease AT carbonnelfranck rollingphenotypeincrohnsdisease AT radfordsmithgraham rollingphenotypeincrohnsdisease |